Cargando…
P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429855/ http://dx.doi.org/10.1097/01.HS9.0000972768.83270.db |
| _version_ | 1785090815658295296 |
|---|---|
| author | Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Srivastava, Shruti Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M |
| author_facet | Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Srivastava, Shruti Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M |
| author_sort | Röth, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104298552023-08-17 P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Srivastava, Shruti Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429855/ http://dx.doi.org/10.1097/01.HS9.0000972768.83270.db Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Röth, Alexander Berentsen, Sigbjørn Barcellini, Wilma D’sa, Shirley Jilma, Bernd Michel, Marc Weitz, Ilene C Yamaguchi, Masaki Nishimura, Jun-Ichi Vos, Josephine Cid, Joan Storek, Michael Wong, Nancy Yoo, Ronnie Jayawardene, Deepthi Srivastava, Shruti Wardęcki, Marek Shafer, Frank Lee, Michelle Broome, Catherine M P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title | P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title_full | P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title_fullStr | P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title_full_unstemmed | P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title_short | P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY |
| title_sort | p1471: sustained efficacy of sutimlimab, a complement c1s inhibitor, in patients with cold agglutinin disease: results from part b of the phase 3 cadenza study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429855/ http://dx.doi.org/10.1097/01.HS9.0000972768.83270.db |
| work_keys_str_mv | AT rothalexander p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT berentsensigbjørn p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT barcelliniwilma p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT dsashirley p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT jilmabernd p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT michelmarc p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT weitzilenec p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT yamaguchimasaki p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT nishimurajunichi p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT vosjosephine p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT cidjoan p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT storekmichael p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT wongnancy p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT yooronnie p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT jayawardenedeepthi p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT srivastavashruti p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT wardeckimarek p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT shaferfrank p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT leemichelle p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy AT broomecatherinem p1471sustainedefficacyofsutimlimabacomplementc1sinhibitorinpatientswithcoldagglutinindiseaseresultsfrompartbofthephase3cadenzastudy |